DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Cortes J, Lipatov O, Im S. et al.
KEYNOTE‑119: Phase 3 study of pembrolizumab versus single-agent chemotherapy for metastatic triple-negative breast cancer.
Ann Oncol 2019;
30 (Suppl. 05) v85-v934
We do not assume any responsibility for the contents of the web pages of other providers.